Literature DB >> 34480223

Highly cited papers in Takayasu arteritis on Web of Science and Scopus: cross-sectional analysis.

Durga Prasanna Misra1, Vikas Agarwal2, Armen Yuri Gasparyan3, Olena Zimba4, Aman Sharma5.   

Abstract

BACKGROUND: Takayasu arteritis (TAK) is a large vessel vasculitis affecting relatively younger population. Since literature on bibliometric analysis of TAK is scarce, we analyzed top-cited articles in TAK to address this knowledge gap.
METHODS: We analyzed the top hundred cited articles in TAK on Web of Science and Scopus for time of publication, article type, country of origin, source journal, and authors. Furthermore, we conducted univariable- and multivariable-adjusted linear regression analyses to explore associations of rank of cited articles, mean number of annual citations, and total citations with traditional (journal impact factor, CiteScore) and alternative (PlumX) metrics.
RESULTS: Concordance between databases was 76%. Most top-cited articles were from the USA, Japan, or the UK, and published in Annals of the Rheumatic Diseases, Arthritis and Rheumatism, and Circulation and Rheumatology (Oxford). Original articles comprised a majority of these top-cited articles. Articles describing criteria or disease management recommendations received the highest mean number of citations. Performing multivariable-adjusted linear regression analyses, years of publication associated with mean annual citations on Web of Science as well as total citations across databases (p < 0.01). The 2-year JIF significantly associated with mean annual citations on Web of Science (p = 0.047). On Scopus, the number of captures denoted under PlumX metrics consistently associated with citations (p < 0.001).
CONCLUSION: Both traditional and alternative metrics associate with higher citations in TAK. Development of disease assessment and clinical practice guidelines and conduct and reporting of randomized controlled trials to guide TAK management are important research areas. The key points themselves are all right. Key Points • A majority of top-cited papers in TAK are original articles. • Both traditional and alternative metrics associate with number of citations for these papers. • Recommendations for disease assessment or clinical practice and clinical trials are important research agenda in TAK.
© 2021. International League of Associations for Rheumatology (ILAR).

Entities:  

Mesh:

Year:  2021        PMID: 34480223     DOI: 10.1007/s10067-021-05901-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

Review 1.  Teaching critical appraisal skills in healthcare settings.

Authors:  Tanya Horsley; Chris Hyde; Nancy Santesso; Julie Parkes; Ruairidh Milne; Ruth Stewart
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Heather Blackmore; George D Kitas
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

3.  Antineutrophil cytoplasmic antibody-associated vasculitides: a scientometric approach visualizing worldwide research activity.

Authors:  Alexander Gerber; Doris Klingelhoefer; David Groneberg; Matthias Bundschuh
Journal:  Int J Rheum Dis       Date:  2014-04-07       Impact factor: 2.454

4.  Bibliometric analysis on global Behçet disease publications during 1980-2014: is there a Silk Road in the literature?

Authors:  E Şenel; E Demir; R M Alkan
Journal:  J Eur Acad Dermatol Venereol       Date:  2016-08-22       Impact factor: 6.166

Review 5.  A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis.

Authors:  Durga Prasanna Misra; Aman Sharma; Tamilarasu Kadhiravan; Vir Singh Negi
Journal:  Autoimmun Rev       Date:  2016-12-15       Impact factor: 9.754

6.  A bibliometric analysis of the global research in ankylosing spondyloarthritis (2008-2017).

Authors:  Xin Zhao; Jiwei Chen; Yangyang Pan; Hai Feng; Bingkun Meng; Ye Meng
Journal:  Rheumatol Int       Date:  2019-04-25       Impact factor: 2.631

Review 7.  Social media for research, education and practice in rheumatology.

Authors:  Olena Zimba; Olena Radchenko; Larysa Strilchuk
Journal:  Rheumatol Int       Date:  2019-12-20       Impact factor: 2.631

Review 8.  Recent advances in the management of Takayasu arteritis.

Authors:  Durga Prasanna Misra; Anupam Wakhlu; Vikas Agarwal; Debashish Danda
Journal:  Int J Rheum Dis       Date:  2019-01       Impact factor: 2.454

9.  Social media platforms: a primer for researchers.

Authors:  Olena Zimba; Armen Yuri Gasparyan
Journal:  Reumatologia       Date:  2021-01-16

Review 10.  A systematic review of clinical and preclinical evidences for Janus kinase inhibitors in large vessel vasculitis.

Authors:  Upendra Rathore; Darpan Radheshyam Thakare; Pallavi Patro; Vikas Agarwal; Aman Sharma; Durga Prasanna Misra
Journal:  Clin Rheumatol       Date:  2021-11-03       Impact factor: 3.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.